Annual Interest Expense
$18.09 M
-$667.00 K-3.56%
December 31, 2024
Summary
- As of February 24, 2025, HALO annual interest expense is $18.09 million, with the most recent change of -$667.00 thousand (-3.56%) on December 31, 2024.
- During the last 3 years, HALO annual interest expense has risen by +$10.57 million (+140.43%).
- HALO annual interest expense is now -17.69% below its all-time high of $21.98 million, reached on December 31, 2017.
Performance
HALO Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$4.54 M
+$16.00 K+0.35%
December 31, 2024
Summary
- As of February 24, 2025, HALO quarterly interest expense is $4.54 million, with the most recent change of +$16.00 thousand (+0.35%) on December 31, 2024.
- Over the past year, HALO quarterly interest expense has stayed the same.
- HALO quarterly interest expense is now -39.58% below its all-time high of $7.51 million, reached on September 30, 2022.
Performance
HALO Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$18.09 M
-$680.00 K-3.62%
December 31, 2024
Summary
- As of February 24, 2025, HALO TTM interest expense is $18.09 million, with the most recent change of -$680.00 thousand (-3.62%) on December 31, 2024.
- Over the past year, HALO TTM interest expense has stayed the same.
- HALO TTM interest expense is now -18.21% below its all-time high of $22.13 million, reached on September 30, 2017.
Performance
HALO TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
HALO Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.6% | 0.0% | 0.0% |
| 3 y3 years | +140.4% | +0.8% | -0.1% |
| 5 y5 years | +55.6% | +0.8% | -0.1% |
HALO Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -3.6% | +140.4% | -39.6% | +158.1% | -14.3% | +147.2% |
| 5 y | 5-year | -11.2% | +140.4% | -39.6% | +159.1% | -14.3% | +147.2% |
| alltime | all time | -17.7% | -100.0% | -39.6% | -100.0% | -18.2% | -100.0% |
Halozyme Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $18.09 M(-3.6%) | $4.54 M(+0.4%) | $18.09 M(-3.6%) |
| Sep 2024 | - | $4.52 M(0.0%) | $18.77 M(+0.1%) |
| Jun 2024 | - | $4.52 M(+0.4%) | $18.76 M(+0.2%) |
| Mar 2024 | - | $4.51 M(-13.7%) | $18.73 M(-0.2%) |
| Dec 2023 | $18.76 M(+10.7%) | $5.22 M(+15.9%) | $18.76 M(+3.6%) |
| Sep 2023 | - | $4.50 M(+0.2%) | $18.11 M(-14.2%) |
| Jun 2023 | - | $4.49 M(-1.1%) | $21.12 M(+7.0%) |
| Mar 2023 | - | $4.54 M(-0.6%) | $19.73 M(+16.4%) |
| Dec 2022 | $16.95 M(+125.2%) | $4.57 M(-39.2%) | $16.95 M(+17.4%) |
| Sep 2022 | - | $7.51 M(+142.1%) | $14.43 M(+66.4%) |
| Jun 2022 | - | $3.10 M(+76.5%) | $8.67 M(+18.5%) |
| Mar 2022 | - | $1.76 M(-14.4%) | $7.32 M(-2.7%) |
| Dec 2021 | $7.53 M(-63.1%) | $2.06 M(+17.2%) | $7.53 M(-28.4%) |
| Sep 2021 | - | $1.75 M(+0.1%) | $10.51 M(-23.5%) |
| Jun 2021 | - | $1.75 M(-10.8%) | $13.74 M(-19.1%) |
| Mar 2021 | - | $1.97 M(-61.0%) | $17.00 M(-16.6%) |
| Dec 2020 | $20.38 M(+75.3%) | $5.04 M(+0.9%) | $20.38 M(+6.8%) |
| Sep 2020 | - | $4.99 M(-0.3%) | $19.07 M(+18.0%) |
| Jun 2020 | - | $5.00 M(-6.4%) | $16.16 M(+17.4%) |
| Mar 2020 | - | $5.35 M(+43.3%) | $13.77 M(+18.4%) |
| Dec 2019 | $11.63 M(-35.6%) | $3.73 M(+79.5%) | $11.63 M(-0.2%) |
| Sep 2019 | - | $2.08 M(-20.5%) | $11.65 M(-15.9%) |
| Jun 2019 | - | $2.61 M(-18.5%) | $13.86 M(-13.5%) |
| Mar 2019 | - | $3.21 M(-14.6%) | $16.02 M(-11.2%) |
| Dec 2018 | $18.04 M | $3.75 M(-12.4%) | $18.04 M(-8.6%) |
| Sep 2018 | - | $4.29 M(-10.1%) | $19.74 M(-6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | $4.77 M(-8.8%) | $21.00 M(-3.5%) |
| Mar 2018 | - | $5.23 M(-4.2%) | $21.77 M(-1.0%) |
| Dec 2017 | $21.98 M(+10.0%) | $5.46 M(-1.4%) | $21.98 M(-0.6%) |
| Sep 2017 | - | $5.54 M(-0.0%) | $22.13 M(+1.3%) |
| Jun 2017 | - | $5.54 M(+1.7%) | $21.84 M(+1.4%) |
| Mar 2017 | - | $5.45 M(-2.7%) | $21.55 M(+7.9%) |
| Dec 2016 | $19.98 M(+284.1%) | $5.60 M(+6.6%) | $19.98 M(+27.4%) |
| Sep 2016 | - | $5.25 M(+0.1%) | $15.68 M(+33.7%) |
| Jun 2016 | - | $5.25 M(+35.4%) | $11.73 M(+50.8%) |
| Mar 2016 | - | $3.88 M(+197.7%) | $7.78 M(+49.5%) |
| Dec 2015 | $5.20 M(-6.8%) | $1.30 M(+0.1%) | $5.20 M(-1.4%) |
| Sep 2015 | - | $1.30 M(+0.2%) | $5.28 M(-1.4%) |
| Jun 2015 | - | $1.30 M(0.0%) | $5.35 M(-2.8%) |
| Mar 2015 | - | $1.30 M(-5.7%) | $5.50 M(-1.4%) |
| Dec 2014 | $5.58 M(+70.5%) | $1.38 M(+0.1%) | $5.58 M(+13.2%) |
| Sep 2014 | - | $1.38 M(-5.2%) | $4.93 M(+11.9%) |
| Jun 2014 | - | $1.45 M(+5.5%) | $4.40 M(+15.8%) |
| Mar 2014 | - | $1.38 M(+89.3%) | $3.80 M(+16.1%) |
| Dec 2013 | $3.27 M(>+9900.0%) | $727.00 K(-14.5%) | $3.27 M(+28.5%) |
| Sep 2013 | - | $850.00 K(+0.1%) | $2.55 M(+50.1%) |
| Jun 2013 | - | $849.00 K(+0.1%) | $1.70 M(+100.1%) |
| Mar 2013 | - | $848.00 K(>+9900.0%) | $848.00 K(>+9900.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2012 | - | $0.00 | $0.00 |
| Dec 2011 | $0.00 | - | - |
FAQ
- What is Halozyme Therapeutics annual interest expense?
- What is the all time high annual interest expense for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual interest expense year-on-year change?
- What is Halozyme Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly interest expense year-on-year change?
- What is Halozyme Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Halozyme Therapeutics?
- What is Halozyme Therapeutics TTM interest expense year-on-year change?
What is Halozyme Therapeutics annual interest expense?
The current annual interest expense of HALO is $18.09 M
What is the all time high annual interest expense for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual interest expense is $21.98 M
What is Halozyme Therapeutics annual interest expense year-on-year change?
Over the past year, HALO annual interest expense has changed by -$667.00 K (-3.56%)
What is Halozyme Therapeutics quarterly interest expense?
The current quarterly interest expense of HALO is $4.54 M
What is the all time high quarterly interest expense for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly interest expense is $7.51 M
What is Halozyme Therapeutics quarterly interest expense year-on-year change?
Over the past year, HALO quarterly interest expense has changed by $0.00 (0.00%)
What is Halozyme Therapeutics TTM interest expense?
The current TTM interest expense of HALO is $18.09 M
What is the all time high TTM interest expense for Halozyme Therapeutics?
Halozyme Therapeutics all-time high TTM interest expense is $22.13 M
What is Halozyme Therapeutics TTM interest expense year-on-year change?
Over the past year, HALO TTM interest expense has changed by $0.00 (0.00%)